Vaxart Inc (VXRT) valuation against sector peers: P/E 3.0 (sector median 30.7), P/B 1.3, EV/EBIT 0.7, free-cash-flow yield 36.4%, P/S 0.5.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.

Metric	VXRT	Sector median	vs median
P/E	3.0	30.7 · n=158	90% below
P/B	1.3	4.0 · n=307	67% below
P/S	0.5	4.1 · n=302	88% below
EV/EBIT	0.7	25.8 · n=146	97% below
Free-cash-flow yield	36.4%	1.4% · n=291	2,475% above
Dividend yield	0.00%	0.00% · n=362	—
Return on equity	62.4%	−2.4% · n=308	—
Return on invested capital	143.3%	0.6% · n=282	22,134% above
Gross margin	—	63.3% · n=205	—
Net debt / EBITDA	−1.85	1.27 · n=151	247% below

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
LLYEli Lilly & Co	48.9	33.5	—	1.5%	0.6%	6/10
JNJJohnson & Johnson	42.0	8.3	—	3.0%	1.9%	8/10
ABBVAbbVie	50.5	—	27.8	3.6%	2.9%	6/10
MRKMerck	148.8	8.1	—	4.0%	2.3%	8/10
UNHUnitedHealth	22.9	3.5	17.3	6.3%	2.2%	10/10
TMOThermo Fisher Scientific	37.6	4.9	35.6	2.9%	0.3%	9/10
AMGNAmgen	26.8	17.5	23.2	3.8%	2.1%	8/10
GILDGilead Sciences	—	16.3	—	6.5%	1.9%	5/10
ABTAbbott	40.7	3.7	32.9	3.5%	2.8%	6/10
PFEPfizer	41.5	1.9	—	7.0%	7.3%	1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Sep 2026 · filed 05 Nov 2026

Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.

Cookie settings